1. Bartholomé, K.: A new molecular defect in phenylketonuria. Lancet 1974II, 1580
2. Bartholomé, K., Lutz, P., Bickel, H.: Determination of Phenylalanine Hydroxylase Activity in Patients with Phenylketonuria and Hyperphenylalaninemia. Pediat. Res. 9, 899?903 (1975)
3. Bartholomé, K., Byrd, D. J.: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine hydroxylase activity. Lancet 1975II, 1042
4. Bartholomé, K., Byrd, D. J., Kaufman, S., Milstien, Sh.: Atypical Phenylketonuria with Normal Phenylalanine Hydroxylase and Dihydropteridine Reductase Activity in Vitro. Pediatrics 59, 757?761 (1977)
5. Brewster, T. G., Abroms, I. F., Kaufman, S., Breslow, J. L., Moskowitz, M. A., Villee, D. B., Snodgrass, R. S.: Atypical PKU, Seizures, and developmental delay with dihydropteridine reductase deficiency. Pediat. Res. 10, 446 (1976)